Dashboard
Manage Tickers

NERV Minerva Neurosciences, Inc.

Nasdaq minervaneurosciences.com


$ 3.70 $ 0.00 (0 %)    

Wednesday, 05-Nov-2025 11:04:22 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 622.36 $ 3.91 (0.63 %)
DIA $ 470.68 $ -0.23 (-0.05 %)
SPY $ 677.34 $ 2.30 (0.34 %)
TLT $ 89.06 $ -0.45 (-0.5 %)
GLD $ 366.08 $ -0.37 (-0.1 %)
$ 3.67
$ 3.50
$ 3.62 x 100
$ 3.76 x 500
-- - --
$ 1.15 - $ 12.46
77,194
na
25.67M
$ 0.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-08-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-02-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-08-2021 12-31-2020 10-K
21 11-02-2020 09-30-2020 10-Q
22 08-03-2020 06-30-2020 10-Q
23 05-04-2020 03-31-2020 10-Q
24 03-09-2020 12-31-2019 10-K
25 11-04-2019 09-30-2019 10-Q
26 08-05-2019 06-30-2019 10-Q
27 05-06-2019 03-31-2019 10-Q
28 03-12-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-03-2018 03-31-2018 10-Q
32 03-12-2018 12-31-2017 10-K
33 11-06-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 03-13-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

minerva-neurosciences-q3-eps-036-misses-035-estimate
Minerva Neurosciences Q3 EPS $(0.36) Misse...
11/05/2025 12:34:03

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/28/2025 21:13:44

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 17:06:27

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 21:06:33

minerva-stock-rises-after-securing-200m-for-schizophrenia-drug-trial
Minerva Stock Rises After Securing $200M f...
10/21/2025 19:11:06

Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding t...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 17:06:45

us-stocks-mixed-coca-cola-posts-upbeat-earnings
US Stocks Mixed; Coca-Cola Posts Upbeat Ea...
10/21/2025 13:50:36

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 12:10:04

minerva-neurosciences-announces-up-to-200m-in-financing-to-advance-roluperidone-for-schizophrenia-through-phase-3-confirmatory-trial-and-nda-resubmission
Minerva Neurosciences Announces Up To $200...
10/21/2025 12:02:23

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 21:06:20

minerva-neurosciences-q2-eps-043-beats-090-estimate
Minerva Neurosciences Q2 EPS $(0.43) Beats...
08/14/2025 20:37:00

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of...

minerva-neurosciences-q1-eps-050-beats-107-estimate
Minerva Neurosciences Q1 EPS $(0.50) Beats...
05/13/2025 11:37:28

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/14/2025 21:06:19

hc-wainwright--co-reiterates-neutral-on-minerva-neurosciences-maintains-5-price-target
HC Wainwright & Co. Reiterates Neutral on ...
02/26/2025 12:32:50

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 ...

minerva-neurosciences-q4-2024-gaap-eps-056-beats-105-estimate-cash-cash-equivalents-and-restricted-cash-at-december-31-2024-were-approximately-215m
Minerva Neurosciences Q4 2024 GAAP EPS $(0...
02/25/2025 12:14:18

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of...

hc-wainwright--co-reiterates-neutral-on-minerva-neurosciences-maintains-5-price-target
HC Wainwright & Co. Reiterates Neutral on ...
11/06/2024 11:56:35

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 ...

minerva-neurosciences-q3-2024-gaap-eps-297-may-not-be-comparable-to-101-estimate
Minerva Neurosciences Q3 2024 GAAP EPS $2....
11/05/2024 13:04:17

Minerva Neurosciences (NASDAQ:NERV) reported quarterly earnings of $2.97 per share which may not be comparable to analyst conse...

hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-5
HC Wainwright & Co. Maintains Neutral on M...
08/07/2024 20:21:42

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

minerva-neurosciences-q2-2024-gaap-eps-109-misses-073-estimate-cash-cash-equivalents-and-restricted-cash-at-june-30-2024-were-approximately-31m
Minerva Neurosciences Q2 2024 GAAP EPS $(1...
08/06/2024 11:43:05

hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-7
HC Wainwright & Co. Maintains Neutral on M...
05/02/2024 17:31:53

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION